Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Moderna, Inc. (MRNA)
Sector: Healthcare; Industry: Biotechnology

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-02-24 Bancel Stephane Chief Executive Officer Sell 19,000 $142.07 $2,699,400 No
2022-02-24 Andres Juan nan Sell 2,000 $150.00 $300,000 Yes
2022-02-16 Andres Juan nan Sell 2,000 $150.00 $300,000 Yes
2022-02-17 Bancel Stephane Chief Executive Officer Sell 19,000 $149.22 $2,835,100 No
2022-02-14 Hoge Stephen President Sell 20,000 $157.71 $3,154,200 Yes
2022-02-10 Andres Juan nan Sell 2,768 $155.55 $430,549 Yes
2022-02-10 Meline David W Chief Financial Officer Sell 619 $158.89 $98,354 Yes
2022-02-10 Bancel Stephane Chief Executive Officer Sell 19,000 $156.25 $2,968,840 No
2022-02-02 Andres Juan nan Sell 2,000 $170.89 $341,780 Yes
2022-02-03 Hoge Stephen President Sell 20,000 $167.94 $3,358,900 Yes
2022-02-03 Bancel Stephane Chief Executive Officer Sell 19,000 $167.79 $3,188,010 No
2022-01-27 Bancel Stephane Chief Executive Officer Sell 19,000 $157.65 $2,995,400 No
2022-01-24 Hoge Stephen President Sell 20,000 $150.67 $3,013,451 Yes
2022-01-20 Bancel Stephane Chief Executive Officer Sell 19,000 $181.42 $3,447,050 No
2022-01-13 Bancel Stephane Chief Executive Officer Sell 19,000 $219.77 $4,175,690 No
2022-01-13 Hoge Stephen President Sell 20,000 $219.67 $4,393,450 Yes
2022-01-06 Bancel Stephane Chief Executive Officer Sell 19,000 $223.27 $4,242,200 No
2021-12-31 Andres Juan nan Sell 5,000 $249.88 $1,249,400 Yes
2022-01-03 Hoge Stephen President Sell 20,000 $247.08 $4,941,600 Yes
2021-12-30 Bancel Stephane Chief Executive Officer Sell 10,000 $243.42 $2,434,200 No
2021-12-29 Andres Juan nan Sell 5,000 $240.00 $1,200,000 Yes
2021-12-29 Bancel Stephane Chief Executive Officer Sell 9,000 $240.00 $2,160,000 No
2021-12-27 Andres Juan nan Sell 10,000 $243.10 $2,431,000 Yes
2021-12-23 Hoge Stephen President Sell 15,000 $247.30 $3,709,548 Yes
2021-12-23 Bancel Stephane Chief Executive Officer Sell 10,000 $250.41 $2,504,100 No
2021-12-22 Andres Juan nan Sell 5,000 $264.26 $1,321,300 Yes
2021-12-22 Bancel Stephane Chief Executive Officer Sell 9,000 $264.26 $2,378,340 No
2021-12-15 Andres Juan nan Sell 5,000 $272.11 $1,360,550 Yes
2021-12-16 Bancel Stephane Chief Executive Officer Sell 19,000 $278.47 $5,290,990 No
2021-12-13 Hoge Stephen President Sell 20,000 $257.01 $5,140,200 Yes

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.